OraSure Technologies, Inc. (OSUR) Analysts See $-0.06 EPS

April 17, 2018 - By Nellie Frank

Investors sentiment decreased to 0.83 in Q4 2017. Its down 0.18, from 1.01 in 2017Q3. It fall, as 45 investors sold OraSure Technologies, Inc. shares while 56 reduced holdings. 34 funds opened positions while 50 raised stakes. 53.79 million shares or 2.08% less from 54.93 million shares in 2017Q3 were reported.
North Carolina-based Comml Bank Of America Corp De has invested 0% in OraSure Technologies, Inc. (NASDAQ:OSUR). First Washington accumulated 254,300 shares or 2.26% of the stock. Metropolitan Life Ins New York holds 17,889 shares or 0% of its portfolio. First Advisors Ltd Partnership holds 0.01% or 111,928 shares in its portfolio. Massachusetts-based Acadian Asset Limited Liability has invested 0.08% in OraSure Technologies, Inc. (NASDAQ:OSUR). Laurion Mgmt L P accumulated 0.01% or 59,200 shares. Invesco invested in 0% or 376,278 shares. Panagora Asset Inc holds 250,909 shares. Louisiana State Employees Retirement Systems owns 0.02% invested in OraSure Technologies, Inc. (NASDAQ:OSUR) for 26,100 shares. Primecap Mgmt Ca invested 0.02% in OraSure Technologies, Inc. (NASDAQ:OSUR). Arrowstreet Limited Partnership holds 0.02% in OraSure Technologies, Inc. (NASDAQ:OSUR) or 402,072 shares. Great West Life Assurance Communications Can holds 0% in OraSure Technologies, Inc. (NASDAQ:OSUR) or 79,373 shares. Credit Agricole S A has 56,000 shares for 0.07% of their portfolio. Deutsche Fincl Bank Ag has 0% invested in OraSure Technologies, Inc. (NASDAQ:OSUR) for 162,140 shares. 37,496 were accumulated by Sector Pension Inv Board.

Since February 15, 2018, it had 0 buys, and 2 insider sales for $778,707 activity. TANG STEPHEN S PHD sold $419,247 worth of stock or 23,333 shares.

Analysts expect OraSure Technologies, Inc. (NASDAQ:OSUR) to report $-0.06 EPS on May, 2.They anticipate $0.27 EPS change or 128.57 % from last quarter’s $0.21 EPS. After having $0.12 EPS previously, OraSure Technologies, Inc.’s analysts see -150.00 % EPS growth. The stock increased 1.68% or $0.29 during the last trading session, reaching $17.59. About 219,959 shares traded. OraSure Technologies, Inc. (NASDAQ:OSUR) has risen 34.91% since April 17, 2017 and is uptrending. It has outperformed by 23.36% the S&P500.

OraSure Technologies, Inc. (NASDAQ:OSUR) Ratings Coverage

Among 3 analysts covering Orasure Technologies (NASDAQ:OSUR), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Orasure Technologies had 8 analyst reports since October 20, 2017 according to SRatingsIntel. Canaccord Genuity maintained it with “Buy” rating and $24.0 target in Friday, February 2 report. Canaccord Genuity maintained the stock with “Buy” rating in Monday, October 23 report. The firm has “Hold” rating given on Tuesday, February 13 by Jefferies. Canaccord Genuity maintained OraSure Technologies, Inc. (NASDAQ:OSUR) on Wednesday, November 22 with “Buy” rating. The firm earned “Hold” rating on Thursday, November 2 by Jefferies. The rating was maintained by Jefferies with “Buy” on Friday, October 20. The stock of OraSure Technologies, Inc. (NASDAQ:OSUR) has “Buy” rating given on Thursday, November 2 by Canaccord Genuity.

OraSure Technologies, Inc., together with its subsidiaries, develops, makes, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company has market cap of $1.08 billion. It operates in two divisions, OSUR and DNAG. It has a 34.49 P/E ratio. The firm also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests.

OraSure Technologies, Inc. (NASDAQ:OSUR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: